BCL2L11 and breast carcinoma: Recent evidence from in vitro experiments suggests an important role for MCL-1 in breast cancer cell survival10,19,20, particularly in triple-negative (TN) breast cancers21–23 and expression of a mutant form of BIM that specifically interacts with MCL-1 inhibits metastases of TN breast cancer cell lines in xenograft models24.